Mitigating intersubjective variability in clinical guidelines
ResearchEquals · 24.11.2025
DOI: 10.53962/nmjw-tsr7 ↗Kurz gefasst
Leitlinie in der Zeitschrift ResearchEquals, online erschienen am 24.11.2025. Verfasst von Gerben ter Riet.
Abstract (Originalsprache)
In this (rejected) response to a JAMA Editorial, coo-authored by one of JAMA's editors on subjectivity in the construction of Clinical Practice Guidelines, we point out that intersubjectivity cannot be avoided therein. However, we show how through stricter rules for guideline committee entry, conflicts of interest can largely be avoided. In addition, transparent application of sensitivity analysis in benefit harm analysis (BHA) helps to steer clear of the problems around subjectivity addressed in the Editorial.
Zitieren
APA
Riet, G. T. (2025). Mitigating intersubjective variability in clinical guidelines. ResearchEquals. https://doi.org/10.53962/nmjw-tsr7
Vancouver
Riet GT. Mitigating intersubjective variability in clinical guidelines. ResearchEquals. 2025. doi:10.53962/nmjw-tsr7
BibTeX
@article{Riet2025,
author = {Riet, Gerben ter},
title = {Mitigating intersubjective variability in clinical guidelines},
journal = {ResearchEquals},
year = {2025},
doi = {10.53962/nmjw-tsr7}
}
EUVIMED